Trial of Maraviroc (UK-427,857) in Combination With Optimized Background Therapy Versus Optimized Background Therapy Alone for the Treatment of HIV-1 Infected Subjects
Public ClinicalTrials.gov record NCT00098722. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of a Novel CCR5 Antagonist, UK-427,857, in Combination With Optimized Background Therapy Versus Optimized Background Therapy Alone for the Treatment of Antiretroviral-Experienced HIV-1 Infected Subjects
Study identification
- NCT ID
- NCT00098722
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2, Phase 3
- Lead sponsor
- ViiV Healthcare
- Industry
- Enrollment
- 474 participants
Conditions and interventions
Conditions
Interventions
- Maraviroc (UK-427,857) Drug
- optimized background therapy Drug
Drug
Eligibility (public fields only)
- Age range
- 16 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 30, 2004
- Primary completion
- Mar 31, 2007
- Completion
- Mar 31, 2011
- Last update posted
- May 15, 2012
2004 – 2011
United States locations
- U.S. sites
- 62
- U.S. states
- 20
- U.S. cities
- 47
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Pfizer Investigational Site | Hobson City | Alabama | 36201 | — |
| Pfizer Investigational Site | Garden Grove | California | 92845 | — |
| Pfizer Investigational Site | Los Angeles | California | 90036 | — |
| Pfizer Investigational Site | Oakland | California | 94609-3480 | — |
| Pfizer Investigational Site | Palm Springs | California | 92262 | — |
| Pfizer Investigational Site | Tarzana | California | 91356 | — |
| Pfizer Investigational Site | Norwalk | Connecticut | 06851 | — |
| Pfizer Investigational Site | Southport | Connecticut | 06490 | — |
| Pfizer Investigational Site | Stratford | Connecticut | 06614 | — |
| Pfizer Investigational Site | Washington D.C. | District of Columbia | 20007 | — |
| Pfizer Investigational Site | Washington D.C. | District of Columbia | 20010-2976 | — |
| Pfizer Investigational Site | Clearwater | Florida | 33765 | — |
| Pfizer Investigational Site | Hollywood | Florida | 33021-6327 | — |
| Pfizer Investigational Site | Miami | Florida | 33137 | — |
| Pfizer Investigational Site | Miami | Florida | 33145 | — |
| Pfizer Investigational Site | Miami | Florida | 33155 | — |
| Pfizer Investigational Site | Miami Beach | Florida | 33139 | — |
| Pfizer Investigational Site | Pensacola | Florida | 32504 | — |
| Pfizer Investigational Site | Safety Harbor | Florida | 34695 | — |
| Pfizer Investigational Site | St. Petersburg | Florida | 33713 | — |
| Pfizer Investigational Site | Tampa | Florida | 33611 | — |
| Pfizer Investigational Site | Tampa | Florida | 33614 | — |
| Pfizer Investigational Site | Atlanta | Georgia | 30309 | — |
| Pfizer Investigational Site | Atlanta | Georgia | 30318-2513 | — |
| Pfizer Investigational Site | Atlanta | Georgia | 30339-3915 | — |
| Pfizer Investigational Site | Jonesboro | Georgia | 30236 | — |
| Pfizer Investigational Site | Chicago | Illinois | 60613 | — |
| Pfizer Investigational Site | Chicago | Illinois | 60657 | — |
| Pfizer Investigational Site | Springfield | Illinois | 62702 | — |
| Pfizer Investigational Site | Metairie | Louisiana | 70006 | — |
| Pfizer Investigational Site | Baltimore | Maryland | 21201 | — |
| Pfizer Investigational Site | Silver Spring | Maryland | 20910 | — |
| Pfizer Investigational Site | Ann Arbor | Michigan | 48109-0008 | — |
| Pfizer Investigational Site | Ann Arbor | Michigan | 48109-0352 | — |
| Pfizer Investigational Site | Detroit | Michigan | 48201 | — |
| Pfizer Investigational Site | Detroit | Michigan | 48202 | — |
| Pfizer Investigational Site | Kansas City | Missouri | 64106 | — |
| Pfizer Investigational Site | St Louis | Missouri | 63139-2909 | — |
| Pfizer Investigational Site | Buffalo | New York | 14215 | — |
| Pfizer Investigational Site | East Meadow | New York | 11554 | — |
| Pfizer Investigational Site | Elmira | New York | 14905 | — |
| Pfizer Investigational Site | New York | New York | 10011 | — |
| Pfizer Investigational Site | New York | New York | 10016 | — |
| Pfizer Investigational Site | New York | New York | 10025 | — |
| Pfizer Investigational Site | New York | New York | 10029 | — |
| Pfizer Investigational Site | Greenville | North Carolina | 27834 | — |
| Pfizer Investigational Site | Akron | Ohio | 44304 | — |
| Pfizer Investigational Site | Cleveland | Ohio | 44109 | — |
| Pfizer Investigational Site | Tulsa | Oklahoma | 74135 | — |
| Pfizer Investigational Site | Portland | Oregon | 97210 | — |
| Pfizer Investigational Site | Portland | Oregon | 97227 | — |
| Pfizer Investigational Site | West Reading | Pennsylvania | 19611 | — |
| Pfizer Investigational Site | Charleston | South Carolina | 29403 | — |
| Pfizer Investigational Site | Charleston | South Carolina | 29425 | — |
| Pfizer Investigational Site | Dallas | Texas | 75219 | — |
| Pfizer Investigational Site | Fort Worth | Texas | 76104 | — |
| Pfizer Investigational Site | Fort Worth | Texas | 76107 | — |
| Pfizer Investigational Site | Pasadena | Texas | 77505-4245 | — |
| Pfizer Investigational Site | Danville | Virginia | 24541 | — |
| Pfizer Investigational Site | Hampton | Virginia | 23666 | — |
| Pfizer Investigational Site | Lynchburg | Virginia | 24501 | — |
| Pfizer Investigational Site | Richmond | Virginia | 23298 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 110 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00098722, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 15, 2012 · Synced May 4, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00098722 live on ClinicalTrials.gov.